Edge BioSystems Overview

  • Founded
  • 1990
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Debt
  • Financing Rounds
  • 5
  • Investments
  • 1

Edge BioSystems General Information

Description

Manufacturer and distributor of sample preparation and clean-up products for use in DNA sequencing. The company's products include sequencing clean-up, PCR purification, sample preparation, competent cells and accessories.

Contact Information

Website
www.edgebio.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Other Devices and Supplies
Parent Company
Primary Office
  • 201 Perry Parkway
  • Suite 5
  • Gaithersburg, MD 20877
  • United States
+1 (800) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Edge BioSystems Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Edge BioSystems‘s full profile, request access.

Request a free trial

Edge BioSystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer and distributor of sample preparation and clean-up products for use in DNA sequencing. The company's produc
Other Devices and Supplies
Gaithersburg, MD
000000000

000000

nsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut eni
00000 0000000 000 00000000
Cambridge, United Kingdom
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edge BioSystems Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 Corporation Cambridge, United Kingdom 00
You’re viewing 1 of 1 competitors. Get the full list »

Edge BioSystems Patents

Edge BioSystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080020443-A1 Simultaneous cloning of genes and expression of recombinant proteins in escherichia coli Abandoned 14-Feb-2006 00000000 0
US-20020042506-A1 Contacting with porous cation and anion exchange resins; does not bind or remove the dna of interest Granted 05-Jul-2000 0000000000
US-6504021-B2 Contacting with porous cation and anion exchange resins; does not bind or remove the dna of interest Expired - Lifetime 05-Jul-2000 0000000000
AU-7974498-A A vector and method for preparation of dna libraries Abandoned 18-Jun-1997 00000000000
EP-1012314-A1 A vector and method for preparation of dna libraries Withdrawn 18-Jun-1997 C12N15/1096

Edge BioSystems Executive Team (3)

Name Title Board Seat Contact Info
Dean Gaalaas Chief Financial Officer
John Seed Ph.D Co-Founder and Chief Technology Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Edge BioSystems Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00000 09-Sep-2015 0000000000 00.00 Specialty Chemicals
To view Edge BioSystems’s complete investments history, request access »

Edge BioSystems Subsidiaries (1)

Company Name Industry Location Founded
0000000 0000000000 Specialty Chemicals San Jose, CA 0000
To view Edge BioSystems’s complete subsidiaries history, request access »